Document Detail


Amrinone versus conventional therapy in pulmonary hypertensive patients awaiting cardiac transplantation.
MedLine Citation:
PMID:  2818057     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Pulmonary hypertension is associated with an increased perioperative mortality for orthotopic heart transplantation. A transpulmonary gradient greater than 15 mm Hg or a pulmonary vascular resistance greater than 5 Woods units increases mortality secondary to right heart failure. This study compares amrinone with conventional therapy in 38 transplant candidates with pulmonary hypertension. All patients had elevated transpulmonary gradient, pulmonary vascular resistance, or both. Group 1 (n = 21) received prolonged continuous intravenous amrinone therapy, whereas group 2 (n = 16) received high-dose oral diuretics, digitalis, and captopril. Both groups 1 and 2 had decreased pulmonary hypertension, transpulmonary gradient, and pulmonary vascular resistance. However, amrinone was more effective, with a 86% response rate versus 63% response for conventional therapy. Survival awaiting transplantation was significantly higher in group 1 (20 of 22, 91%) than in group 2 (10 of 16, 63%). Although both groups 1 and 2 had significantly decreased pulmonary vascular resistance, only group 2 had significantly decreased systemic vascular resistance. Comparison of pulmonary vascular resistance after therapy showed that the response in group 1 (amrinone) was significantly lower than the response in group 2 (conventional therapy), suggesting that amrinone may function as a direct vasodilator of the pulmonary vasculature. There were no operative deaths or episodes of perioperative right heart failure in either group. Amrinone appears to be more effective and safe than conventional therapy in the treatment of prospective heart transplant candidates with pulmonary hypertension.
Authors:
G M Deeb; S F Bolling; T P Guynn; J M Nicklas
Related Documents :
17913247 - Protective effect of pulmonary surfactant on cilia of eustachian tube in otitis media w...
16534477 - Lung transplantation for pulmonary langerhans' cell histiocytosis: a multicenter analysis.
10529557 - Donor lung pretreatment with prostaglandin e(1) does not improve lung graft preservation.
19201337 - Impact of graft volume reduction for oversized grafts after lung transplantation on out...
19696637 - Successful reduction of immunosuppression in older renal transplant recipients who exhi...
6419807 - Comparison of aortography, renal vein renin sampling, radionuclide scans, ultrasound an...
Publication Detail:
Type:  Comparative Study; Journal Article    
Journal Detail:
Title:  The Annals of thoracic surgery     Volume:  48     ISSN:  0003-4975     ISO Abbreviation:  Ann. Thorac. Surg.     Publication Date:  1989 Nov 
Date Detail:
Created Date:  1989-12-18     Completed Date:  1989-12-18     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  15030100R     Medline TA:  Ann Thorac Surg     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  665-9     Citation Subset:  AIM; IM    
Affiliation:
University of Michigan Medical Center, Ann Arbor.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Amrinone / therapeutic use*
Angiotensin-Converting Enzyme Inhibitors / therapeutic use
Digitalis Glycosides / therapeutic use
Diuretics / therapeutic use
Female
Heart Transplantation*
Humans
Hypertension, Pulmonary / drug therapy*
Male
Middle Aged
Premedication*
Retrospective Studies
Chemical
Reg. No./Substance:
0/Angiotensin-Converting Enzyme Inhibitors; 0/Digitalis Glycosides; 0/Diuretics; 60719-84-8/Amrinone

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Reconstruction of the esophagus with the left colon.
Next Document:  De Vega's annuloplasty for acquired tricuspid disease: early and late results in 110 patients.